Tevogen (TVGN) Debt Ratio (2024)
Tevogen Bio Holdings' (TVGN) quarterly Debt Ratio came in at 0.24 in Q3 2024.
Tevogen (TVGN) Debt Ratio (2024) Analysis & Trends
Tevogen Bio Holdings (TVGN) has 1 years of Debt Ratio data on file, last reported at 0.24 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.65 Bn | 130.80 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.93 Bn | 77.94 Bn | 3.93 Bn | 0.05 |
| 3 | Argenx Se | 64.84 Bn | 59.66 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.38 Bn | 52.25 Bn | 52.00 Mn | 0.05 |
| 5 | BeOne Medicines | 41.94 Bn | 36.84 Bn | 1.53 Bn | 0.12 |
| 6 | Alnylam Pharmaceuticals | 31.54 Bn | 28.23 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 27.72 Bn | 9.33 Bn | 668.28 Mn | 0.03 |
| 8 | Insmed | 27.49 Bn | 26.33 Bn | 358.27 Mn | 0.26 |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - | 0.47 |
| 10 | Tevogen | 25.73 Mn | 25.73 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 0.24 |